<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" lang="en">
<head>
<meta http-equiv="default-style" content="application/xhtml+xml; charset=utf-8" />
<title>Clinical Anesthesia Fundamentals, 2e</title>
<link rel="stylesheet" type="text/css" href="css/style.css"/>
<script type="text/javascript" src="js/video-insert.js"></script>
</head>
<body epub:type="bodymatter">
<div id="main_container">
<section epub:type="division">
<h4 class="h4" id="sec231">VI. Minimally Invasive Cardiac Surgery</h4>
<p class="nonindent">Advances in technology have made minimally invasive cardiac surgical approaches possible in an attempt to avoid complete median sternotomy, aortic cross clamping, and CPB. Decreased time to extubation, decreased length of stay in the intensive care unit, decreased transfusion rates, and decreased incidence of postoperative atrial fibrillation are cited as benefits of minimally invasive cardiac surgery. Although reduction in neurocognitive dysfunction was a primary goal of minimally invasive cardiac surgery, randomized controlled studies have had disappointing results in this area.<sup><a href="ch036-sec08.xhtml#bib8">8</a></sup> Minimally invasive cardiac surgery procedures are available for CHD as well as VHD.</p>
<p class="indent">However, procedures through small incisions in the chest are technically very challenging. Inexperience with minimally invasive techniques can lead to very significant complications, including inadequate valve repair, paravalvular leaks, and coronary obstruction. Catheter-based percutaneous valve repair and replacement are becoming more common in the United States. These techniques may be best suited for patients who have a history of previous sternotomy or very high perioperative risk of mortality.</p>
<p class="video"><video data-id="vPQTt23G" controls="controls" class="jwp-video" crossorigin="anonymous" style="width:100%; height:auto; width:320px; height:240px;">Browser issues</video></p>
<p class="video1" id="vid36-10"><strong>VIDEO 36.10</strong></p>
<p class="video2"><strong>Dobutamine</strong></p>
<a id="page780"></a>
<div class="table">
<p class="TABLEpNUM" id="tt36-6"><strong><span class="tab">Table&#160;36.6</span> Medications Given by Continuous Infusion</strong></p>
<table class="table">
<colgroup>
<col style="width:33%;"></col>
<col style="width:33%;"></col>
<col style="width:34%;"></col>
</colgroup>
<tr>
<td class="theadleft"><strong>Drugs</strong></td>
<td class="theadleft"><strong>Usual Initial Dose (mg/kg/min)</strong></td>
<td class="theadleft"><strong>Usual Dose Range (mg/kg/min)</strong></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>Amrinone</strong><sup><a id="ftn1a" href="#ftn1">a</a></sup></p></td>
<td class="td2"><p class="tbodyleft">2-5</p></td>
<td class="td2"><p class="tbodyleft">2-20</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>Dopamine</strong></p></td>
<td class="td3"><p class="tbodyleft">2-5</p></td>
<td class="td3"><p class="tbodyleft">2-20</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>Dobutamine</strong></p></td>
<td class="td2"><p class="tbodyleft">2-5</p></td>
<td class="td2"><p class="tbodyleft">2-20</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>Epinephrine</strong></p></td>
<td class="td3"><p class="tbodyleft">0.01</p></td>
<td class="td3"><p class="tbodyleft">0.01-0.1</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>Isoproterenol</strong><sup><a id="ftn2a" href="#ftn2">b</a></sup></p></td>
<td class="td2"><p class="tbodyleft">0.05-1</p></td>
<td class="td2"><p class="tbodyleft">0.1-1</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>Lidocaine</strong></p></td>
<td class="td3"><p class="tbodyleft">20</p></td>
<td class="td3"><p class="tbodyleft">20-50</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>Milrinone</strong></p></td>
<td class="td2"><p class="tbodyleft">50&#x00A0;&#x03BC;g/kg (over 3 min)</p></td>
<td class="td2"><p class="tbodyleft">0.3-0.7</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>Nitroglycerin</strong></p></td>
<td class="td3"><p class="tbodyleft">0.5</p></td>
<td class="td3"><p class="tbodyleft">0.5-5</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>Nitroprusside</strong></p></td>
<td class="td2"><p class="tbodyleft">0.5</p></td>
<td class="td2"><p class="tbodyleft">0.5-5</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>Norepinephrine</strong></p></td>
<td class="td3"><p class="tbodyleft">0.1</p></td>
<td class="td3"><p class="tbodyleft">0.1-1</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>Phenylephrine</strong></p></td>
<td class="td2"><p class="tbodyleft">1</p></td>
<td class="td2"><p class="tbodyleft">1-3</p></td>
</tr>
<tr>
<td class="td3"><p class="tbodyleft"><strong>Prostaglandin E</strong><sub>1</sub></p></td>
<td class="td3"><p class="tbodyleft">0.05-0.1</p></td>
<td class="td3"><p class="tbodyleft">0.05-0.2</p></td>
</tr>
<tr>
<td class="td2"><p class="tbodyleft"><strong>Vasopressin</strong></p></td>
<td class="td2">&#x00A0;</td>
<td class="td2"><p class="tbodyleft">0.0004</p></td>
</tr>
</table>
<p class="tfoot"><sup><a id="ftn1" href="#ftn1a">a</a></sup>Requires initial bolus of 750&#x00A0;&#x03BC;g/kg over 3 min before start of infusion.</p>
<p class="u_tfoot"><sup><a id="ftn2" href="#ftn2a">b</a></sup>For chronotropic effect following cardiac transplantation, doses of 0.005 to 0.010&#x00A0;&#x03BC;g/kg/min are used.</p>
<p class="u_tfoot">From Skubas NJ, Lichtman AD, Wang CJ, Sharma A, Thomas SJ. Anesthesia for cardiac surgery. In: Barash PG, Cahalan MK, Cullen BF, et al, eds. <em>Clinical Anesthesia</em>. 8th ed. Wolters Kluwer; 2018:1077-1111, Table 39.18.</p>
</div>
</section>
</div>
</body>
</html>